SMAD7 and breast carcinoma: Bao et al. have reported that Smad7 mediates the SOX7 and Axin-2 regulation of the Wnt/β-catenin pathway to influence to progression of breast cancer [18], whereas by targeting Smad7, miR-15b inhibit the osteogenic differentiation of bone mesenchymal stem cells [19].